Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines.
Chow, L
Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines. [electronic resource] - The Prostate May 2008 - 651-60 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0270-4137
10.1002/pros.20738 doi
Cell Line, Tumor
DNA--biosynthesis
Epidermal Growth Factor--metabolism
Gene Expression Regulation, Neoplastic--drug effects
Humans
Male
Mitogen-Activated Protein Kinase 1--metabolism
Phosphorylation
Prostatic Neoplasms--genetics
RNA, Messenger--metabolism
RNA, Neoplasm--analysis
Receptor, Angiotensin, Type 1--genetics
Receptor, Angiotensin, Type 2--physiology
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction--drug effects
Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines. [electronic resource] - The Prostate May 2008 - 651-60 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0270-4137
10.1002/pros.20738 doi
Cell Line, Tumor
DNA--biosynthesis
Epidermal Growth Factor--metabolism
Gene Expression Regulation, Neoplastic--drug effects
Humans
Male
Mitogen-Activated Protein Kinase 1--metabolism
Phosphorylation
Prostatic Neoplasms--genetics
RNA, Messenger--metabolism
RNA, Neoplasm--analysis
Receptor, Angiotensin, Type 1--genetics
Receptor, Angiotensin, Type 2--physiology
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction--drug effects